# Dose Escalation Study of PF-06741086 In Healthy Subjects

> **NCT02531815** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 41 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** PF-06741086
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02531815
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2016-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02531815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02531815, "Dose Escalation Study of PF-06741086 In Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02531815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*